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Introduction {#sec1}
============

Nitrogen-containing compounds widely occur in biologically active molecules including natural products ([@bib33]), agrochemicals, and pharmaceuticals ([@bib23]). In particular, over 90% of pharmaceuticals contain at least one nitrogen atom in their structures, so the development of efficient approaches to *N*-heterocycles is of paramount importance ([@bib6], [@bib10]). Compounds containing a l,8-diazabicyclo\[3.3.0\]octane skeleton exhibit diverse biological activities. For example, they are used as the androgen receptor modulator ([@bib41]), angiotensin II receptor antagonist ([@bib24]), and DNA topoisomerase inhibitor ([Figure 1](#fig1){ref-type="fig"}) ([@bib20]). However, 1*H*-pyrazolo\[5,1-*a*\]isoindol-2(8*H*)-ones as their derivatives have been ignored ([@bib17]). To the best of our knowledge, enantioselective synthesis of this kind of compounds containing a quaternary stereocenter has not been reported thus far.Figure 1Selected Bioactive Compounds with a Diazabicyclo\[3.3.0\]octane Skeleton

Since the pioneering work by Cacchi and co-workers ([@bib5], [@bib1]; [@bib4], [@bib2]), the palladium-catalyzed hydroarylation or reductive Heck reaction of aryl halides (pseudohalides) with alkenes has attracted much attention ([@bib40], [@bib22], [@bib16], [@bib9], [@bib8], [@bib34], [@bib13], [@bib7], [@bib11], [@bib32]). However, the development of highly enantioselective hydroarylation is still a great challenge, and only some examples of the enantioselective protocols have been reported till now ([@bib27], [@bib26], [@bib25], [@bib45], [@bib35], [@bib21]). It is well known that the enantioselectivity highly depends on structures of chiral ligands in the transition-metal-catalyzed asymmetric synthesis, so the development of new chiral ligands is crucial ([@bib37], [@bib28]). In this regard, the axially chiral diphosphine ligands have been proved to be highly efficient in various enantioselective transformations ([@bib31], [@bib47], [@bib36], [@bib43], [@bib29], [@bib18], [@bib19], [@bib12], [@bib3], [@bib39], [@bib15], [@bib14]). Recently, we have developed a kind of novel axially chiral cyclo-\[1,1′-biphenyl\]-2,2′-diols (CYCNOL) with adjustable dihedral angles ([@bib46]), and the chiral cyclic phosphoramidite ligands derived from CYCNOL have been successfully applied in iridium-catalyzed enantioselective arylation of unactivated racemic secondary allylic alcohols ([@bib38]) and synthesis of dihydroimidazoquinazolinones ([@bib30]). Inspired by the ligands we developed ([@bib46], [@bib38], [@bib30]), we herein report a palladium-catalyzed intramolecular enantioselective hydroarylation by elaborate tuning of newly developed axially chiral cyclic diphosphine ligands derived from CYCNOL.

Results and Discussion {#sec2}
======================

Synthesis of Ligands {#sec2.1}
--------------------

Racemic CYCNOL, *Rac*-CYC-8-NOL, *Rac*-CYC-9-NOL, and *Rac*-CYC-10-NOL, were prepared according to our previous procedures ([@bib46]). Subsequently, synthesis (following Zhou\'s protocol \[[@bib44]\]) and resolution of our axially chiral cyclic diphosphine ligands were performed ([Figure 2](#fig2){ref-type="fig"}) (see [Supplemental Information](#appsec3){ref-type="sec"} for details).Figure 2Synthesis of Axially Chiral Cyclic Diphosphine Ligands

Crystal Structures of Ligands {#sec2.2}
-----------------------------

Single crystals of the axially chiral cyclic diphosphine ligands (*S*)-CYC-8-BIPHP ((*S*)-**E**), (*S*)-CYC-9-BIPHP ((*S*)-**F**), and (*S*)-CYC-10-BIPHP ((*S*)-**G**) from mixed hexane and dichloromethane solvent were prepared, and their structures were unambiguously confirmed by X-ray diffraction analysis (see [Supplemental Information](#appsec3){ref-type="sec"}, [Data S1](#mmc2){ref-type="supplementary-material"}, [S2](#mmc3){ref-type="supplementary-material"}, and [S3](#mmc4){ref-type="supplementary-material"} for details). According to the data from X-ray diffraction analysis, dihedral angles of the diphosphine ligands showed remarkable difference with a variety of ring sizes ([Figure 3](#fig3){ref-type="fig"}). It is known to all that the reactivity and enantioselectivity of substrates in the transition metal asymmetric synthesis are closely related to the structures of the ligands, such as the dihedral angles of axially chiral ligands.Figure 3Crystal Structures and Dihedral Angles of Axially Chiral Cyclic Diphosphine Ligands (*S*)-**E**, (*S*)-**F**, and (*S*)-**G**

Optimization Study {#sec2.3}
------------------

At first, palladium-catalyzed enantioselective hydroarylation of 1-(2-iodobenzyl)-5-methyl-2-phenyl-1*H*-pyrazol-3(2*H*)-one (**1a**) leading to (*S*)-3*a*-methyl-1-phenyl-3,3*a*-dihydro-1*H*-pyrazolo\[5,1-*a*\]isoindol-2(8*H*)-one (**2a**) was used as the model to optimize conditions including catalysts, ligands, tertiary amines, acids, solvents, and temperature. As shown in [Table 1](#tbl1){ref-type="table"}, seven ligands including four common diphosphine ligands, (*S*)- 2,2′- bis(diphenylphosphino)-1,1′-binaphthyl (BINAP), (*R*)- 5,5′-bis\[di(3,5-di-t-butyl-4-methoxyphenyl)phosphino\]-4,4′-bi-1,3-benzodioxole (DTBM-SEGPHOS), (*S*)-MeO-BIPNEP, and (*S*)- 7,7′-bis(diphenylphosphino)-2,2′,3,3′-tetrahydro-1,1′-spirobiindane (SDP), and our three cyclic diphosphine ligands, (*S*)-**E**, (*S*)-**F,** and (*S*)-**G**, were screened using Pd(trifluoroacetic acid \[TFA\])~2~ as the catalysts and *N*,*N*-dimethylbenzylamine/TFA as the hydride donors in *N*,*N*-dimethylacetamide (DMA) under a nitrogen atmosphere at 150°C for 24 hr (entries 1--7). We were pleased to find that the three cyclic diphosphine ligands, (*S*)-**E**, (*S*)-**F**, and (*S*)-**G**, all provided high yields with excellent enantiomeric excess (ee) values (entries 5--7), in which (*S*)-**F** was optimal (entry 6). Compared with the four common ligands, the advantage of our cyclo-\[1,1′-biphenyl\]diphosphine ligands, (*S*)-**E**, (*S*)-**F,** and (*S*)-**G**, is attributed to their combination of conformational rigidity and flexibility because they own the rigid biphenyl and the flexible full-carbon 6,6′-tethers. Meanwhile, the three cyclo-diphosphine ligands had little influence on the yields and ee values because of this factor. Single crystal of product **2a** in entry 6 from mixed hexane and dichloromethane solvent was prepared, and its absolute configuration was determined to be *S*-form based on its single-crystal X-ray analysis ([Table 1](#tbl1){ref-type="table"}) (see [Supplemental Information](#appsec3){ref-type="sec"} and [Data S4](#mmc5){ref-type="supplementary-material"} for details). Racemic **2a** was obtained in 37% yield in the absence of ligand (entry 8). When other three tertiary amines, triethylamine, diisopropylethylamine, and proton sponge, were used instead of *N*,*N*-dimethylbenzylamine, lower ee values were observed (entries 9--11). Only a small amount of product **2a** was found in the absence of amine (entry 12). Use of HOAc or HCOOH or absence of acid led to lower yields (entries 13--15). Two more palladium catalysts, Pd(dba)~2~ and Pd(OAc)~2~, were tested (entries 16 and 17), and they were inferior to Pd(TFA)~2~ (compare entries 6, 16, and 17). The effect of solvents was surveyed, and DMA proved to be a suitable solvent (compare entries 6, 18, and 19). When ligand (*S*)-**F** was increased from 7.5 mol % to 10 mol % (entry 20), the same yield and ee value were observed (compare entries 6 and 20). We attempted variation of temperature (entries 21 and 22), and the results showed that 150°C was a suitable temperature (compare entries 6, 21, and 22). According to the aforementioned results, we think that Pd(TFA)~2~ as the catalyst; (*S*)-**E**, (*S*)-**F,** and (*S*)-**G** as the ligands; *N*,*N*-dimethylbenzylamine/TFA as the hydride donor; and DMA as the solvent are suitable in the present palladium-catalyzed intramolecular enantioselective hydroarylation.Table 1Optimization of Conditions![](fx2.gif)EntryLigandAmineAcidYield of 2a (%)[a](#tblfn1){ref-type="table-fn"}ee of 2a (%)[b](#tblfn2){ref-type="table-fn"}1(*S*)-**A**BnNMe~2~TFA68232(*R*)-**B**BnNMe~2~TFA31−593(*S*)-**C**BnNMe~2~TFA63284**(*S*)-D**BnNMe~2~TFA73−25(*S*)-**E**BnNMe~2~TFA7096**6(*S*)-FBnNMe**~2~**TFA7697**7(*S*)-**G**BnNMe~2~TFA73968--BnNMe~2~TFA3709(*S*)-**F**NEt~3~TFA769310(*S*)-**F**DIPEATFA759211(*S*)-**F**PSTFA578812(*S*)-**F**--TFA89413(*S*)-**F**BnNMe~2~HOAc489514(*S*)-**F**BnNMe~2~HCOOH379615(*S*)-**F**BnNMe~2~--359616[c](#tblfn3){ref-type="table-fn"}(*S*)-**F**BnNMe~2~TFA519517[d](#tblfn4){ref-type="table-fn"}(*S*)-**F**BnNMe~2~TFA639618[e](#tblfn5){ref-type="table-fn"}(*S*)-**F**BnNMe~2~TFA629619[f](#tblfn6){ref-type="table-fn"}(*S*)-**F**BnNMe~2~TFA569520[g](#tblfn7){ref-type="table-fn"}(*S*)-**F**BnNMe~2~TFA769721[h](#tblfn8){ref-type="table-fn"}(*S*)-**F**BnNMe~2~TFA389722[i](#tblfn9){ref-type="table-fn"}(*S*)-**F**BnNMe~2~TFA7696[^2][^3][^4][^5][^6][^7][^8][^9][^10][^11][^12]

Scope of the Investigation {#sec2.4}
--------------------------

After obtaining the optimized conditions, the substrate scope for the palladium-catalyzed intramolecular enantioselective hydroarylation of **1** was surveyed using (*S*)-**F** as the ligand. As shown in [Figure 4](#fig4){ref-type="fig"}, we first attempted variation of substituents R^1^ in **1**; various alkyl groups including methyl, ethyl, propyl, isopropyl, cyclopropyl, cyclopentyl, phenethyl, and phenpropyl were feasible, and the reaction provided high reactivity (76%--83% yields) and excellent enantioselectivity (97%--99% ee) (see **2a-h**). When substituents R^1^ in **1** were different substituted benzyls, their enantioselectivity was also excellent (98%--99% ee) (see **2i-m**). Subsequently, variation of substituents R^2^ in **1** was investigated (see **2n-ad**). For substituents R^2^ with different substituted phenyls, the influence of electronic effect including electron-donating (see **2n-t**), slight electron-withdrawing (see **2u-w**), and strong electron-withdrawing groups (see **2x-z**) on the phenyl rings was slight, and high reactivity (74%--84% yields) and excellent enantioselectivity (97%--99% ee) of the substrates were observed. When substituents R^2^ were benzyl (see **2aa** and **2ab**) and cyclohexyl (see **2ac** and **2ad**), the reaction also afforded high yields and excellent ee values. Variation of substituents R^3^ on the phenyl rings was investigated, and excellent results were obtained (see **2ae-ah**).Figure 4Substrate Scope for Palladium-Catalyzed Asymmetric Cyclization of 1Reaction conditions: under nitrogen atmosphere, 1-(2-iodobenzyl)-5-alkyl-2-alkyl-1*H*-pyrazol-3(2*H*)-one (**1**) (0.2 mmol, 1.0 equiv), Pd(TFA)~2~ (10 μmol, 5 mol%), (*S*)-**F** (15 μmol, 7.5 mol%), BnNMe~2~ (1.0 mmol, 5 equiv), TFA (0.4 mmol, 2 equiv), DMA (4.0 mL), temperature (150°C), time (24 hr) in a sealed tube. Isolated yield was obtained, and the ee values were determined by high-performance liquid chromatography analysis. Absolute configurations of products **2** were determined by comparing structure of (*S*)-**2a** (absolute configuration of (*S*)-**2a** was assigned by X-ray diffraction analysis). Bn, benzyl. See [Transparent Methods](#mmc1){ref-type="supplementary-material"} for experimental details.

Next, influence of the cyclic diphosphine ligands, (*S*)-**E**, (*S*)-**F,** and (*S*)-**G**, with different dihedral angles was investigated ([Figure 4](#fig4){ref-type="fig"}), and we found that the different substrates exhibited slight difference in reactivity and enantioselectivity with variation of the ligands. For all the tested substrates, (*S*)-**F** containing nine-membered ring was a suitable ligand. For synthesis of **2b** and **2y**, (*S*)-**G** containing ten-membered ring showed slightly higher enantioselectivity than (*S*)-**E**, which contained an eight-membered ring and (*S*)-**F**. The present reaction showed tolerance of various functional groups including C-F, C-Cl, and C-Br bonds and ether, CF~3~, nitro, cyano, ester, and amide groups. It is worthwhile to note that substrates **1** have unactivated 2-iodobenzy unit. In fact, it was usually difficult for the reaction of the substrates with this unit in previous report, and an effective solution was the use of substituted 2-halobenzoyls with high reactivity as the alternatives of 2-iodobenzy unit ([@bib35]). In addition, no erosion of ee values was observed at such high temperature (150°C). The results showed that our catalyst system was highly efficient in the present reaction.

Applications of the Method {#sec2.5}
--------------------------

A scale synthesis of (*S*)-**2i** was performed as example. As shown in [Figure 5](#fig5){ref-type="fig"}A, reaction of **1i** (2.15 mmol, 1.0 g) under standard conditions provided (*S*)-**2i** in 82% yield with 98% ee without loss of yield and enantioselectivity. We attempted the reaction of aryl bromide **3** under the conditions ([Figure 5](#fig5){ref-type="fig"}B), and (*S*)-**2a** was obtained in 38% yield with 97% ee. Furthermore, reduction of (*S*)-**2i** with LiAlH~4~ provided (*S*)-**4** in 95% yield with 98% ee without loss of ee ([Figure 5](#fig5){ref-type="fig"}C).Figure 5Applications of the Method(A) Scale synthesis of (*S*)-**2i**.(B) Palladium-catalyzed asymmetric cyclization of 1-(2-bromobenzyl)-5-methyl-2-phenyl-1*H*-pyrazol-3(2*H*)-one (**3**).(C) Reduction of (*S*)-**2i**.

Mechanism of the Reaction {#sec2.6}
-------------------------

According to the experiments mentioned above and previous references ([@bib32], [@bib27]), a reaction pathway of this palladium-catalyzed intramolecular enantioselective hydroarylation is proposed in [Figure 6](#fig6){ref-type="fig"}. Oxidative addition of the aryl iodide **1** to the *in situ*-formed Pd(0) diphosphine complex leads to the Pd(II) intermediate **I**, and then anion exchange of **I** with the salt (BnNHMe~2~^+-^O~2~CCF~3~) provides **II**. Carbopalladation of the double bond in **II** yields the *π*-oxa-allyl palladium species **III**. A hydride transfer from the CH~2~ of benzyl in BnNMe~2~ to palladium gives the Pd(II) hydride complex **IV** leaving the iminium ion **V**. Reductive elimination of the Pd(II) hydride complex **IV** finally affords the target product (**2**) with regeneration of Pd(0)L\*.Figure 6Possible Mechanism for the Palladium-Catalyzed Intramolecular Asymmetric Hydroarylation

Extension of the Method {#sec2.7}
-----------------------

Furthermore, the palladium-catalyzed intramolecular asymmetric hydroarylation of *o*-iodobenzoyl derivatives (**5**) was attempted under conditions similar to those in ([Figures 4](#fig4){ref-type="fig"} and [7](#fig7){ref-type="fig"}), and we found that *o*-iodobenzoyl derivatives (**5**) exhibited higher reactivity and lower enantioselectivity than *o*-iodobenzy derivatives (**1**). Unfortunately, the factors that lead to lower enantioselectivity of **6** than **2** are unknown for us.Figure 7Palladium-Catalyzed Intramolecular Asymmetric Hydroarylation of *o*-Iodobenzoyl Derivatives (5)

Limitations of Study {#sec2.8}
--------------------

It should be pointed out that there are limitations to the present method including requirement of higher temperature and maladjustment of other common ligands.

Conclusions {#sec2.9}
-----------

In summary, we have developed an efficient and highly enantioselective palladium-catalyzed intramolecular hydroarylation, in which the reactivity and enantioselectivity of the substrates were tuned by our newly developed axially chiral cyclic diphosphine ligands and the new kind of *N*-heterocycles, 1*H*-pyrazolo\[5,1-*a*\]isoindol-2(8*H*)-ones containing a quaternary stereocenter, were prepared in high yields and excellent ee values with numerous functional group tolerance. We believe that our axially chiral cyclic diphosphine ligands with the adjustable dihedral angles will find wide application in asymmetric synthesis.

Methods {#sec3}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Data and Software Availability {#appsec1}
==============================

Crystallographic data have been deposited in the Cambridge Crystallographic Data Center under accession numbers CCDC: [1842685](ccdc:1842685){#intref0010}, [1822026](ccdc:1822026){#intref0015}, [1842686](ccdc:1842686){#intref0020}, and [1822025](ccdc:1822025){#intref0025}.
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[^1]: Lead Contact

[^2]: Reaction conditions: under nitrogen atmosphere, 1-(2-iodobenzyl)-5-methyl-2-phenyl-1*H*-pyrazol-3(2*H*)-one (**1a**) (0.2 mmol, 1.0 equiv), Pd(TFA)~2~ (10 μmol, 5 mol%), ligand (15 μmol, 7.5 mol%), amine (1.0 mmol, 5 equiv), acid (0.4 mmol, 2 equiv), *N*,*N*-dimethylacetamide (DMA) (4.0 mL), temperature (150^°^C), time (24 hr) in a sealed Schlenk tube. Absolute configuration of (*S*)-**2a** was assigned by X-ray diffraction analysis.

[^3]: PS, proton sponge; DMF, *N,N*-dimethylformamide; DMSO, dimethylsulfoxide.

[^4]: Isolated yield.

[^5]: The ee values were determined by high-performance liquid chromatography analysis.

[^6]: Using Pd(dba)~2~ (10 μmol, 5 mol%) as the catalyst.

[^7]: Using Pd(OAc)~2~ (10 μmol, 5 mol%) as the catalyst.

[^8]: Using DMF (4.0 mL) as the solvent.

[^9]: Using DMSO (4.0 mL) as the solvent.

[^10]: Using (*S*)-**F** (20 μmol, 10 mol%) as the ligand.

[^11]: The reaction was carried out at 130°C.

[^12]: The reaction was carried out at 160°C.
